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reprogrammable multifunctional manipulator designed to 
move materials, parts, tools, or specialized devices through 
variable programmed motions for the performance of a 
variety of tasks defined by The Robotics Institute of America. 
Dependent on the degree of automation and autonomy 
different classes can be recognized. Examples where robotic 
systems are used in brachytherapy are e.g. in prostate and 
bladder implantations. 
Several commercial and non-commercial systems exist to 
plan and place needles into the prostate. These systems can 
be automated for radioactive seed delivery and HDR 
treatments. Clinical study show robotic implantations to be 
feasible, although still manual corrections are done. 
In bladder brachytherapy a laparoscopic robotic system is 
available for catheter placement without the need to open 
the bladder (cystotomy). As with the traditional way of 
implanting, the catheters can be placed parallel and 
equidistantly. The major advantage is reduction of treatment 
morbidity with this technique, although also misplacements 
have been observed preventing adequate brachytherapy. 
Development of new technologies, such as robotic-aided 
brachytherapy implantations is welcomed to increase the 
precision and reproducibility of treatments and reduce 
morbidity. On the other side it should be appreciated that 
also for these techniques a learning curve exist. Clinical 
results in comparison to the traditional techniques should be 
awaited and carefully discussed before widespread 
adaptation of these new techniques. 
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Interventional radiotherapy (brachytherapy) was the first 
medical application in the treatment of cancer after 
discovering radium. User experience was growing over the 
time and useful rules of meaningful applicaton were 
developed. For many decades this experience based rules 
regulated the indication as well the performance of 
brachytherapy applications. After introducing milestone 
developments in the technical performance (stepping source 
technology and modern treatment planning software 
packages) as well in target definition modalities 
(multiparametric imaging, real-time imaging) and in quality 
assurance issues (medical & physical QA) biological planning 
and intensity modulation potential become available. 
Furthermore, interdisciplinary networking and education in 
the field lead to a higher level of cure rates with low toxicity 
and better Quality of Life of the patients. Economical 
comparison with other methods proved the necessity of 
involving interventional radiotherapy in to modern function 
preservative interdisciplinary treatments.  
Head & Neck cancer represents a special need for 
interdisciplinary cooperation because:  
1. Most of the recurrences following modern external beam 
radiotherapy (with or without complementary systemic 
treatment) are in-field recurrences. This indicates the need 
for higher local dose and interventional radiotherapy offers 
the highest possible dose in a small volume accompanied by 
very low radiation dose on surrounding normal tissues or 
organs at risk.  
2. Aggressive surgery cause functional or cosmetic demages 
on the head & neck. The combination of surgery and 
perioperative interventional radiotherapy results in higher 
rates of function preservation or in better cosmetic results.  
3. Modern multiparametric imaging techniques including 
hypoxia imaging has the potential to guide necessary very 
high dose areas to the right but very small volumes within the 
target.  
Regarding healthcare economy issues: preliminary analyses of 
healthcare professionals stated the advantage of involving 
interventional radiotherapy in to the treatment of head & 
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Vaginal cancer is a rare disease, accounting for only 2-3% of 
all gynaecological cancers. The majority (85%) of the tumours 
are squamous cell carcinomas and associated with a previous 
HPV infection.  
The FIGO classification is used for clinical staging and is an 
important prognostic factor. Approximately 25% of patients 
present with FIGO stage I, limited to the vaginal wall with a 
5-year survival rate of approximately 80%, compared to 20% 
for FIGO stage IV tumours that invade other pelvic organs or 
extend beyond the true pelvis (10-15% of patients). Other 
known prognostic factors are site, size and histologic 
subtype.  
The treatment of vaginal cancer may include surgery in 
limited stage I disease, in the upper third of the vagina. 
However, surgery is often extensive especially if tumors 
extend to the lower two thirds of the vagina and it is often 
difficult to achieve negative margins in tumors larger than 2-
3 cm. Because of these difficulties, radiotherapy is generally 
recommended as the standard treatment for all vaginal 
cancers irrespectively of the stage.  
In general, radiotherapy is very similar to that for cervical 
cancer and includes a combination of 45-50 Gy external beam 
radiotherapy (EBRT) with concomitant weekly cisplatinum 
followed by brachytherapy boost to a total dose of 70 Gy to 
80 Gy. With regard to the brachytherapy technique small 
residual tumors (≤5mm thick) can be treated with 
intracavitary technique alone while combined intracavitary 
and interstitial technique should be considered for larger 
tumours.  
Published data on the results of radiotherapy are mainly 
based on small retrospective studies and can be categorised 
in two groups. The first group includes studies where patients 
mainly were treated with 2-dimensional (x-ray based) 
radiotherapy. The second small group includes studies where 
patients have been treated using image guided (CT or MRI) 
adaptive treatment planning. Any direct comparison between 
the two groups of studies is difficult because of the 
retrospective nature of the data, limited number of patients 
and short follow-up. However, it seems that image guided 
brachytherapy is associated an increased local control rate 
from 75% (44-87%) for the radiograph based studies to 85% 
(75-94%) for the studies using an image guided approach, 
together with a decrease in moderate to severe treatment 
related morbidity. In 2005 the GEC-ESTRO GYN group 
successfully introduced an image guided adaptive target 
concept for brachytherapy in locally advanced cervical 
cancer. This concept takes the initial tumour extent at time 
of diagnosis as well as tumour regression during EBRT into 
account. Several studies have shown a therapeutic benefit 
with improvements in local control and reductions in 
moderate to severe morbidity using this concept.  
Based on these results, a task group within GEC ESTRO GYN 
was formed with the aim to introduce image guided adaptive 
target concept in the treatment of vaginal cancer. This 
initiative started in the beginning of 2014 comparing the 
different target concepts from each of the 5 involved 
centres. In a next step each centre contoured 5 different 
cases with their own target concept in mind. During this work 
many similarities were found in the target concepts and 
between the contours of each centre. Therefore the group 
proceeded to investigate the differences and similarities in 
dose and treatment planning. In this project each centre 
performed treatment planning for the 5 contoured cases 
using both their own target contours and on a set of contours 
that were provided.  
Importantly, radiotherapy for vaginal cancer is based on a 
combination of clinical findings as well as imaging. Especially 
for the clinical findings the precise documentation can be 
challenging. In order to increase the uniform reporting a 
clinical drawing for this documentation has been developed. 
